TAFI gene polymorphisms in patients with cerebral venous thrombosis.

about

Sex-specific effect of CPB2 Ala147Thr but not Thr325Ile variants on the risk of venous thrombosis: A comprehensive meta-analysis Polymorphism of thrombin-activatable fibrinolysis inhibitor and risk of intracranial haemorrhage in factor XIII deficiency.

P2860

Q33731941-FB403DF5-25FF-4955-BA7D-5150C0DCD108 Q45859203-7FF233E9-5BAE-4B00-BCD3-A673B7D19545

P2860

TAFI gene polymorphisms in patients with cerebral venous thrombosis.

Item

http://www.wikidata.org/entity/Q53127456

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

TAFI gene polymorphisms in patients with cerebral venous thrombosis.

@en

TAFI gene polymorphisms in patients with cerebral venous thrombosis.

@nl

type

Item

label

TAFI gene polymorphisms in patients with cerebral venous thrombosis.

@en

TAFI gene polymorphisms in patients with cerebral venous thrombosis.

@nl

prefLabel

TAFI gene polymorphisms in patients with cerebral venous thrombosis.

@en

TAFI gene polymorphisms in patients with cerebral venous thrombosis.

@nl

P1476

TAFI gene polymorphisms in patients with cerebral venous thrombosis

@en

P2093

Alper Sinan

http://www.w3.org/2001/XMLSchema#string

Hatice Gul Durakbasi-Dursun

http://www.w3.org/2001/XMLSchema#string

Mithat Tavli

http://www.w3.org/2001/XMLSchema#string

Nurhan Ilhan

http://www.w3.org/2001/XMLSchema#string

Osman Yilmaz

http://www.w3.org/2001/XMLSchema#string

Sennur Demirel

http://www.w3.org/2001/XMLSchema#string

Serhat Tokgoz

http://www.w3.org/2001/XMLSchema#string

P2860

Cerebral venous thrombosis: diagnosis and management.

Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic stroke.

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor.

Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men

TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study.

Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties.

Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia.

Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism.

Risk of ischemic stroke associated with functional thrombin-activatable fibrinolysis inhibitor plasma levels.

Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation.

P2888

s13760-012-0170-6

P304

291-297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13760-012-0170-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Ayse Gul Zamani

P577

2012-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233977144

http://www.w3.org/2001/XMLSchema#string

P698

23264082

http://www.w3.org/2001/XMLSchema#string

P921

thrombosis

TAFI gene polymorphisms in patients with cerebral venous thrombosis.

about

P2860

P2860

TAFI gene polymorphisms in patients with cerebral venous thrombosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921